Prevalence of localized scleroderma in a specialized dermatology center in the State of Ceará, Brazil
DOI:
https://doi.org/10.11606/issn.1679-9836.v99i6p568-572Keywords:
Epidemiology, Dermatology, Rheumatology, Scleroderma, localizedAbstract
Introduction: Scleroderma encompasses a broad spectrum of clinical manifestations, being subdivided into localized and systemic forms. The localized form exclusively affects the skin and surrounding tissues and has a partially known physiopathology and epidemiology, with the majority of epidemiological studies focusing on the systemic form and extrapolating its results to the other one. This study aim to clarify the epidemiology of localized scleroderma in the state of Ceará, Brazil, in order to understand its risk factors in the Brazilian population. This is the first Brazilian epidemiological study of localized scleroderma. Methods: A quantitative retrospective study was conducted, in which all the records of the medical consultations performed at the Reference Center for Dermatology Dona Libânia (CDERM), Fortaleza, Ceará, Brazil, in 2015 were analysed using the variables: name, gender, date of consultation, medical record number, presumptive or confirmed diagnosis and the patient’s frequency in CDERM. Results: Of the 19.576 patients analysed, 124 were diagnosed with scleroderma, representing an approximate incidence of 0.62% in the service. Among these patients, 96 (77.42%) were female and 28 (22.58%) were male. The mean age of the patients was 29.7 years. Discussion: Prevalence and distribution by sex obeyed the worldwide trends reported in other studies. However, there was a higher prevalence of diagnoses in females in the pediatric age group, which contrasts with data in the literature affirming that differences in gender distribution only begin in early adolescence. This difference may be due to cultural factors, underdiagnosis in the male population or a regional trend in the Brazilian epidemiology of localized scleroderma. Conclusion: More extensive and multicentric studies are needed to better understand the disease in our population and, thus, serve as a basis for healthcare in the future.
Downloads
References
Gaubitz M. Epidemiology of connective tissue disorders. Rheumatology. 2006;45(3):33-4. https://doi.org/10.1093/rheumatology/kel282.
Fett N, Werth VP. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2011;64(2):217-28. https://doi.org/10.1016/j.jaad.2010.05.045
Parodi A. Morphea (localized scleroderma). In: European Handbook of Dermatological Treatments. 3rd ed. Berlin: Springer; 2015. p.637-42. https://doi.org/10.1007/978-3-662-45139-7_64.
Zancanaro PC, Isaac AR, Garcia LT, Costa IM. Esclerodermia localizada na criança: aspectos clínicos, diagnósticos e terapêuticos. An Bras Dermatol. 2009;84(2):161-72. https://doi.org/10.1590/S0365-05962009000200009.
Fett N. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies. Clin Dermatol. 2013;31(4):432-7. https://doi.org/10.1016/j.clindermatol.2013.01.010.
Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermatol. 2009;145(5):545-50. http://doi.org/10.1001/archdermatol.2009.79.
Birdi N, Laxer RM, Thorner P, Fritzler MJ, Silverman ED. Localized scleroderma progressing to systemic disease. Case report and review of the literature. Arthritis Rheum. 1993;36:410-5. https://doi.org/10.1002/art.1780360318.
Zulian F, Athreya B, Laxer R, Nelson A, Feitosa de Oliveira S, Punaro M, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology. 2005;45(5):614-20. https://doi.org/10.1093/rheumatology/kei251.
Christen-Zaech S, Hakim MD, Afsar FS, Paller AS. Pediatric morphea (localized scleroderma): review of 136 patients. J Am Acad Dermatol. 2008;59(3):385-96. https://doi.org/10.1016/j.jaad.2008.05.005.
Kreuter A. Localized scleroderma. Dermatol Ther. 2012;25(2):135-47. https://doi.org/10.1111/j.1529-8019.2012.01479.x.
Li SC. Scleroderma in children and adolescents: localized scleroderma and systemic sclerosis. Pediatr Clin North Am. 2018;65(4):757‐81. https://doi.org/10.1111/j.1529-8019.2012.01479.x.
Peterson LS, Nelson AM, Su WP, Mason T, O’Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol. 1997;24:73-80.
Condie D, Grabell D, Jacobe H. Comparison of outcomes in adults with pediatric-onset morphea and those with adult-onset morphea: a cross-sectional study from the morphea in adults and children cohort. Arthritis Rheumatol. 2014;66(12):3496‐504. https://doi.org/10.1002/art.38853.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Thais Campelo Bedê Vale, Levi Coelho Maia Barros, Matheus Eugênio de Sousa Lima, Mariana Rocha Maia, Maria Araci Pontes Aires
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
